Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Ozempic
Recent news which mentions Ozempic
< Previous
1
2
3
4
5
6
Next >
These Foods Have An Ozempic-Like Effect And Could Help You Lose Weight
November 01, 2023
Tickers
NVO
Tags
Benzinga
weight loss drugs
wegovy
From
Benzinga
Robbie Williams Attributes Weight Loss To Ozempic-Like Drug In Upcoming Netflix Documentary: 'It's Like A Christmas Miracle'
October 29, 2023
Tags
Market News
Entertainment
Stories That Matter
From
Benzinga
Is Ozempic Killing Liposuction? A Stock That Could Get Hit Hard From New Weight-Loss Drugs
October 27, 2023
Tickers
JNJ
LLY
NVO
Tags
weight loss drugs
Health Care
JNJ
From
Benzinga
Weight Loss Drugs Wegovy, Ozempic Gain Traction With Millennials, High Earners: New Survey Results
October 26, 2023
Tickers
KO
LLY
NVO
PEP
Tags
beverage stocks
food stocks
KO
From
Benzinga
Is Your Weight-loss Medication Genuine? Demand For Drugs From Novo Nordisk And Eli Lilly Leads To Surge In Counterfeits
October 21, 2023
Tickers
LLY
NVO
Tags
Markets
NVO
Counterfeit
From
Benzinga
Nestlé To Develop Products For Users Of 'Miracle' Weight-Loss Drugs Like Ozempic, Wegovy
October 20, 2023
Tickers
NSRGY
Tags
General
Biotech
News
From
Benzinga
Are People Done Buying Chips And Soda? Stock Market Winners And Losers From Rise Of Ozempic, Weight-Loss Drugs
October 19, 2023
Tickers
CAVA
CMG
MCD
MDLZ
Tags
Benzinga
MDLZ
Weight Loss
From
Benzinga
Novo Nordisk Ups Outlook Amid Surging Demand For Weight Loss Drug Wegovy, Ozempic
October 14, 2023
Tickers
NVO
Tags
Weight Loss Drug
Novo Nordisk
Benzinga
From
Benzinga
Novo Nordisk's Kidney Outcomes Trial Has Broad Industry Implications
October 12, 2023
Tickers
DVA
LLY
NVO
Tags
Market News
Health Care
DVA
From
Benzinga
Eli Lilly To Fly Higher? Fund Manager Gary Black Envisions Blockbuster Potential For Diabetes Drug Mounjaro
October 12, 2023
Tickers
FFND
LLY
NVO
Tags
Health Care
Morgan Stanley
Specialty ETFs
From
Benzinga
Demand For Packaged Food Drops In US: Has 'Miracle' Drug Ozempic Got Something To Do With It?
October 10, 2023
Tickers
CAG
GIS
K
KHC
Tags
Benzinga
News
Ozempic
From
Benzinga
Pepsi Q3 Earnings Preview: Will Beverage Giant See Shares Lose More Weight In 2023?
October 09, 2023
Tickers
KO
PEP
Tags
Gerald Pascarelli
weight loss drugs
KO
From
Benzinga
Experts Weigh In On Ozempic's Evolving Side Effects And How To Handle Them
October 09, 2023
Tickers
NONOF
Tags
weightloss
Novo Nordisk
Benzinga
From
Benzinga
Elon Musk Claims Ozempic Has Impacted Walmart's Sales, Seemingly Gives Endorsement To Drug
October 08, 2023
Tickers
WMT
Tags
Benzinga
Top Stories
AI/Generated
From
Benzinga
Snacks In The Ozempic Era: Food, Beverage Stocks Crash With Weight Loss Drugs On The Rise
October 06, 2023
Tickers
BRBR
CAG
CPB
FOOD
Tags
Sector ETFs
Markets
food
From
Benzinga
Walmart Reports 'Slight Pullback' In Food Demand As 'Miracle' Weight-Loss Drug Ozempic Gains Popularity
October 05, 2023
Tickers
NVO
WMT
Tags
General
Biotech
News
From
Benzinga
Sharon Osbourne Decides To Quit 'Miracle' Weight Loss Drug Ozempic: 'I Didn't Want To Go This Thin'
September 25, 2023
Tags
weightloss
Sharon Osbourne
Benzinga
From
Benzinga
Coca-Cola Short Seller Says Dominance Fizzles In Face Of Bubbly Upstarts, Weight Loss Drugs
September 21, 2023
Tickers
BRK
BRK-A
BRK-B
CELH
Tags
Market News
Short Sellers
wegovy
From
Benzinga
Did Ozempic Play A Role In A Man's Suicide? Family Seeks Warning Label
September 11, 2023
Tickers
NONOF
Tags
General
Media
Ozempic
From
Benzinga
Ozempic Might Eliminate Daily Insulin Injections For Type 1 Diabetes Patients
September 07, 2023
Tags
Ozempic
Media
News
From
Benzinga
Australian Influencer Thought She Was 'Going To Die' After Overdosing On 'Miracle' Weight Loss Drug Ozempic
September 04, 2023
Tags
Market News
Health Care
Benzinga
From
Benzinga
Ozempic Maker Beats Bernard Arnault's LVMH As Europe's Most Valuable Firm With Stunning $423B Market Cap
September 04, 2023
Tickers
LVMHF
LVMUY
NVO
Tags
weight/loss drugs
Market News
Equities
From
Benzinga
Erika Jayne Pushes Back Against Claims Of Taking Weight Loss Drug Ozempic: 'I've Always Been Tiny'
August 30, 2023
Tags
Erika Jayne
Health Care
Market News
From
Benzinga
Weight-Loss Drug Ozempic Sparks Frenzy In Cyprus Despite Limited Accessibility
August 27, 2023
Tags
Diabetes
weightloss
Benzinga
From
Benzinga
Kim Kardashian's Slim Waistline Sparks Speculation About Ozempic Use: 'What Waist'
August 26, 2023
Tags
Kim Kardashian
Diabetes
weightloss
From
Benzinga
Novo Nordisk Eyes Social Inequality To Enhance Access To Wegovy: 'Have To Be More Intentional'
August 25, 2023
Tickers
NVO
Tags
Lars Fruergaard Jorgensen
NVO
Media
From
Benzinga
Darcey Silva Accused Of Using 'Miracle' Drug Ozempic After Showing Dramatic Weight Loss
August 25, 2023
Tags
Health Care
Market News
Entertainment
From
Benzinga
Republican Congressman George Santos Shed 92 Pounds With 'Miracle' Weight Loss Drug Ozempic: Report
August 25, 2023
Tags
Novo Nordisl
weightloss
Diabetes
From
Benzinga
These Three New Markets May Propel Novo Nordisk's Ozempic To Greater Heights
August 25, 2023
Tickers
NVO
Tags
General
Ozempic
News
From
Benzinga
Ozempic Diet: Foods To Avoid For Minimized Side Effects
August 24, 2023
Tags
News
Ozempic
Media
From
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.